VIRGINIA RETIREMENT SYSTEMS ET AlVIRGINIA RETIREMENT SYSTEMS ET Al

Institutional investor · Portfolio as of Q3 2023

SEC EDGAR SourceSEC Filings

Top Holdings935 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

APPLE INC

3.4M$585.7M5.8%$97.48+73.60%
24 qtrssince 2017-Q3
Decreased
0

MICROSOFT CORP

1.5M$487.5M4.8%$121.73+155.06%
24 qtrssince 2017-Q3
Increased
61

BROADCOM INC

215,891$179.3M1.8%$49.64+62.88%
21 qtrssince 2018-Q2
Unchanged
0

NVIDIA CORP

403,979$175.7M1.7%$20.20+115.16%
24 qtrssince 2017-Q3
Increased
49

ALPHABET INC-CL A

1.3M$170M1.7%$97.37+33.39%
24 qtrssince 2017-Q3
Increased
48

AMAZON.COM INC

1.3M$167.1M1.7%$114.35+11.17%
24 qtrssince 2017-Q3
Decreased
0

META PLATFORMS INC-CLASS A

463,696$139.2M1.4%$182.14+63.68%
24 qtrssince 2017-Q3
Decreased
0

CISCO SYSTEMS INC

2.5M$132.2M1.3%$43.70+14.70%
24 qtrssince 2017-Q3
Decreased
0

ALPHABET INC-CL C

948,800$125.1M1.2%$96.46+35.67%
24 qtrssince 2017-Q3
Increased
50

MERCK & CO. INC.

1.2M$124.5M1.2%$64.96+47.62%
24 qtrssince 2017-Q3
Decreased
0

BERKSHIRE HATHAWAY INC-CL B

352,100$123.3M1.2%$198.93+76.09%
24 qtrssince 2017-Q3
Unchanged
0

REGENERON PHARMACEUTICALS

128,454$105.7M1.0%$632.93+29.31%
24 qtrssince 2017-Q3
Increased
52

VERTEX PHARMACEUTICALS INC

297,900$103.6M1.0%$221.27+57.16%
17 qtrssince 2019-Q2
Unchanged
0

GILEAD SCIENCES INC

1.3M$100.6M1.0%$65.15+6.54%
5 qtrssince 2022-Q3
Increased
45

KLA CORP

210,492$96.5M1.0%$305.52+47.13%
24 qtrssince 2017-Q3
Decreased
0

ARCHER-DANIELS-MIDLAND CO

1.2M$88.7M0.9%$48.49+42.52%
24 qtrssince 2017-Q3
Increased
44

TESLA INC

353,131$88.4M0.9%$248.07+0.87%
13 qtrssince 2020-Q2
Increased
44

VISA INC-CLASS A SHARES

381,121$87.7M0.9%$170.78+32.16%
24 qtrssince 2017-Q3
Unchanged
0

JPMORGAN CHASE & CO

602,638$87.4M0.9%$94.64+44.83%
24 qtrssince 2017-Q3
Increased
49
PLDPLD
REIT

PROLOGIS INC

744,786$83.6M0.8%$75.50+38.11%
24 qtrssince 2017-Q3
Decreased
0
$10.1B
AUM
935
Positions
Q3 2023
Filing
Rating · 1.5
Quarterly Portfolio Change
-27%Q1'22$10.7B-17%Q3'22$8.8B+9%Q4'22$9.6B+1%Q1'23$9.7B+8%Q2'23$10.4B-3%Q3'23$10.1B
Activity profile
$ moved · Q3'23
New8%Increased37%Decreased38%Exited17%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.1 years
<1Q3%1-4Q7%1-2Y11%2Y+79%

VIRGINIA RETIREMENT SYSTEMS ET Al manages $10.1B across 935 positions as of Q3 2023. Top holdings: AAPL (5.8%), MSFT (4.8%), AVGO (1.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q3 2023 Summary

Active quarter - 120 new positions, 148 exits, 408 increased. Top move: MSFT (INCREASED, conviction 61). Portfolio: $10.1B across 935 positions.

Top holdings by portfolio weight

Total AUM$10B
AAPL5.78%
MSFT4.81%
AVGO1.77%
NVDA1.74%
GOOGL1.68%
AMZN1.65%
META1.37%
CSCO1.30%
GOOG1.24%
MRK1.23%
Other1.22%

Portfolio allocation by GICS sector

Sectors11
Technology23.88%
Healthcare14.67%
Financial Services11.34%
Industrials10.38%
Consumer Cyclical10.19%
Consumer Defensive7.10%
Real Estate6.92%
Communication Services6.33%
Energy2.80%
Basic Materials2.52%
Other3.89%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Financial Services
Compare DNA across all funds
7-dimension quality assessment

Last filed Q4 2025 - no longer filing.

Below Average(1.5 / 5.0)
Track RecordNo data
Conviction41
Concentration0
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
PECOPECOPHILLIPS EDISON & COMPANY IN
Q1 2025 Q4 2025+37,738 shares+$1.4M
4Q
WELLWELLWELLTOWER INC
Q1 2025 Q4 2025+261,400 shares+$61.8M
4Q
BCRXBCRXBIOCRYST PHARMACEUTICALS INC
Q1 2025 Q4 2025+186,254 shares+$1.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used